Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myelomaMarco Ladetto, Benedetto Bruno, Daniela Drandi et al.|Leukemia|2015Cited by 36
Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myelomaLuisa Giaccone, Benedetto Bruno, Paola Omedè et al.|Bone Marrow Transplantation|2015Cited by 6
Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple MyelomaBenedetto Bruno, Marco Ladetto, Paola Omedè et al.|Blood|2014Cited by 5
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic LeukemiaLuisa Giaccone, Filippo Marmont, Umberto Vitolo et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3
Immunophenotypic Response After Allografting In Multiple MyelomaLuisa Giaccone, Benedetto Bruno, Paola Omedè et al.|Blood|2013Cited by 2